The risks of infection transmission by blood transfusion in England.
作者信息
Soldan K, Barbara J
机构信息
PHLS COSC, London, UK.
出版信息
J Clin Pathol. 1999 Jun;52(6):405-8. doi: 10.1136/jcp.52.6.405.
Abstract
摘要
相似文献
1
The risks of infection transmission by blood transfusion in England.英国输血导致感染传播的风险。
J Clin Pathol. 1999 Jun;52(6):405-8. doi: 10.1136/jcp.52.6.405.
2
Emily Cooley Memorial Award. Managing change to improve transfusion safety.艾米丽·库利纪念奖。管理变革以提高输血安全性。
Transfusion. 2004 Sep;44(9):1377-83. doi: 10.1111/j.0041-1132.2004.04183.x.
3
Zika Virus and Patient Blood Management.寨卡病毒与患者血液管理
Anesth Analg. 2017 Jan;124(1):282-289. doi: 10.1213/ANE.0000000000001770.
4
Research, monitoring, and policy issues related to emerging pathogens.
Vox Sang. 2002 Aug;83 Suppl 1:351-4. doi: 10.1111/j.1423-0410.2002.tb05332.x.
5
Residual risks of blood transfusion in Rhode Island.罗德岛输血的残余风险。
Med Health R I. 2005 Jul;88(7):224-5, 228-31.
6
Towards the holy grail of the infection-free blood transfusion.
Commun Dis Public Health. 2004 Mar;7(1):8-10.
7
JAMA patient page. Avoiding diseases transmitted by blood and body fluids.《美国医学会杂志》患者专页。避免血液和体液传播的疾病。
JAMA. 2000 Jul 12;284(2):268.
8
Evolution of microbial safety.微生物安全性的演变
Hematol J. 2004;5 Suppl 3:S69-73. doi: 10.1038/sj.thj.6200426.
9
Bacterial contamination of cellular blood products: the Canadian perspective.细胞血液制品的细菌污染：加拿大的观点。
Transfus Sci. 2000 Aug;23(1):17-9. doi: 10.1016/s0955-3886(00)00052-7.
10
Efforts Toward Elimination of Infectious Agents in Blood Products.努力消除血液制品中的感染因子。
J Intensive Care Med. 2018 Oct;33(10):543-550. doi: 10.1177/0885066618756589. Epub 2018 Mar 21.
引用本文的文献
1
Effect of low dose tranexamic acid on intra-operative blood loss in neurosurgical patients.低剂量氨甲环酸对神经外科手术患者术中失血的影响。
Saudi J Anaesth. 2015 Jan;9(1):42-8. doi: 10.4103/1658-354X.146304.
本文引用的文献
1
Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992 to 1996.1992年至1996年英格兰和威尔士丙型肝炎病毒感染的实验室监测
Commun Dis Public Health. 1998 Jun;1(2):89-94.
2
Nucleic acid technology (NAT) testing and the transfusion service: a rationale for the implementation of minipool testing.核酸技术（NAT）检测与输血服务：实施微池检测的基本原理
Transfus Med. 1998 Mar;8(1):9-13. doi: 10.1046/j.1365-3148.1998.00130.x.
3
Is Creutzfeldt-Jakob disease transmitted in blood?克雅氏病会通过血液传播吗？
Emerg Infect Dis. 1997 Apr-Jun;3(2):155-63. doi: 10.3201/eid0302.970208.
4
Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors.1型人类免疫缺陷病毒血清转化前病毒和血清学标志物检测的时间进程：对血液和组织供者筛查的意义
Transfusion. 1995 Feb;35(2):91-7. doi: 10.1046/j.1537-2995.1995.35295125745.x.
5
Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA.通过第三代酶联免疫吸附测定法提高输血后肝炎中抗丙型肝炎病毒的检测率。
Vox Sang. 1995;68(1):15-8. doi: 10.1111/j.1423-0410.1995.tb02538.x.
6
A study of anti-hepatitis C positive blood donors: the first year of screening.抗丙型肝炎阳性献血者研究：筛查的第一年
Transfus Med. 1994 Jun;4(2):125-33. doi: 10.1111/j.1365-3148.1994.tb00253.x.
7
Hepatitis of the non-A, non-B type following blood transfusion in the north London region.伦敦北部地区输血后非甲非乙型肝炎
Med Lab Sci. 1981 Oct;38(4):423-6.
Zotero 插件